PMC full text:
Published online 2004 Feb 22. doi: 10.1038/nm1001
Figure 2
![An external file that holds a picture, illustration, etc.
Object name is 41591_2004_Article_BFnm1001_Fig2_HTML.jpg An external file that holds a picture, illustration, etc.
Object name is 41591_2004_Article_BFnm1001_Fig2_HTML.jpg](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095986/bin/41591_2004_Article_BFnm1001_Fig2_HTML.jpg)
Antiviral activity of pegylated IFN-α against SCV in vitro and its biological activity in macaques.
(a) Effect of pegylated IFN-α against SCV infection in vitro. Similar results were obtained in three separate experiments. (b) Pharmacokinetic analysis of pegylated IFN-α (b) and induction of neopterin (c) in macaques treated with PBS (□, control group; n = 4) or pegylated IFN-α (▪, prophylactic group; n = 4) on days −3 and −1. Data are expressed as mean ± s.d. **, P < 0.01 compared with control.